Searchable abstracts of presentations at key conferences in endocrinology

ea0049gp100 | Diabetes therapy & complications 1 | ECE2017

Type 1 diabetes and hearing loss: a meta-analysis

Mujica-Mota Mario , Patel Neel

Objective: Evidence shows type 1 diabetes leads to vascular damage and neuropathy. The purpose of this study was to perform a systematic review and a meta-analysis to asses the evidence of the effects of type 1 diabetes on hearing function.Methods: Three different electronic databases were used to identify eligible studies including a manual searching of references. The articles obtained were independently reviewed by two authors using predefined inclusi...

ea0077op6.1 | Endocrine Cancer and Late Effects | SFEBES2021

Incidental findings are common, but rarely clinically significant, in patients with Neuroendocrine Tumours undergoing Gallium68 Dotatate PET CT; results from a one year retrospective review

Garrahy Aoife , Tadman Mike , Slater Viv , Moore Niall , Coupe Nicholas , Weaver Andrew , Soonawalla Zahir , Patel Neel , May Christine , Jafar Mohammadi Bahram

Gallium68-Dotatate PET-CT is a somatostatin-receptor (SSTR) based imaging modality employed in the diagnosis and follow-up of Neuroendocrine Tumours (NET). We set out to investigate the incidence of incidental findings, some of which are related to SSTR expression, in our NET patient cohort in Oxford University Hospital. Sixty-eight patients underwent Gallium68-Dotatate PET-CT between June 2020 and June 2021. 40 patients (59%) were female, and median age ...

ea0068p31 | Abstracts | UKINETS2019

Transformation of non-functional metastatic pancreatic neuroendocrine tumour to functional insulinoma; a rare but recognised phenomenon

Anguelova Lia , Healy Ultan , Tadman Michael , Weaver Andrew , Fryer Eve , Patel Neel , Boardman Phillip , Soonawalla Zahir , May Christine , Pal Aparna , Grossman Ashley , Jafar-Mohammadi Bahram

We present the case of a 54-year-old woman with known metastatic non-functional pancreatic NET since 2004 that developed new debilitating recurrent hypoglycemia in 2013. The patient presented in 2004 with disseminated malignancy. Radiology revealed a large pancreatic mass associated with multiple liver lesions and abdominal lymphadenopathy. Liver biopsy confirmed well differentiated NET. Initial treatment with cisplatin etoposide chemotherapy was poorly tolerated and discontin...

ea0068p16 | Abstracts | UKINETS2019

Clinical characteristics and outcomes of 23 patients with insulinoma: a single centre retrospective observational study 2011–2018

Healy Ultan , Tadman Michael , Weaver Andrew , Fryer Eve , Bailey Adam , Patel Neel , Boardman Phil , Soonawalla Zahir , Pal Aparna , May Christine JH , Thakker Raj V , Grossman Ashley B , Jafar-Mohammadi Bahram

We report a retrospective, single centre observational study to determine the characteristics and outcomes of pancreatic insulinoma. Interrogation of the Oxford NET database, a departmental database of new NET MDT referrals since 2011 (n = 1059), revealed 23/1059 (2.1%) patients with insulinoma diagnosed and treated between 2011 and 2018. Patient records were reviewed and data was captured on demographics, presentation, investigations, treatments and outcomes: 15/23 (...